Related references
Note: Only part of the references are listed.Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and Steatosis
Olga Protchenko et al.
HEPATOLOGY (2021)
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Ji Feng et al.
ACTA PHARMACOLOGICA SINICA (2021)
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Zhong-jie Li et al.
ACTA PHARMACOLOGICA SINICA (2021)
Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis
Yanchun Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Ferroptosis: molecular mechanisms and health implications
Daolin Tang et al.
CELL RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA
Qi Wang et al.
EXPERIMENTAL CELL RESEARCH (2021)
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications
Junyan Tao et al.
HEPATOLOGY (2021)
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species
Derek Lee et al.
HEPATOLOGY (2021)
Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy
Xianchuang Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Artesunate Regulates Neurite Outgrowth Inhibitor Protein B Receptor to Overcome Resistance to Sorafenib in Hepatocellular Carcinoma Cells
Wubin He et al.
FRONTIERS IN PHARMACOLOGY (2021)
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation
Jialei Sun et al.
REDOX BIOLOGY (2021)
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
Junru Chen et al.
CANCER LETTERS (2021)
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
Qiujie Wang et al.
CELL DEATH & DISEASE (2021)
O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
Guoqing Zhu et al.
CELL DEATH DISCOVERY (2021)
Monitoring and modulating O-GlcNAcylation: assays and inhibitors of O-GlcNAc processing enzymes
Matthew G. Alteen et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
Qikai Sun et al.
HEPATOLOGY (2020)
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
Yanfeng Liu et al.
NATURE COMMUNICATIONS (2020)
Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
Xu Yao et al.
ACTA PHARMACOLOGICA SINICA (2020)
Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
Yingying Yu et al.
BLOOD (2020)
Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma
Chie Ishikawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma
Can G. Leineweber et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells
Do Hyung Kim et al.
CELL DEATH & DISEASE (2020)
Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells
Yuxue Shang et al.
CELLULAR SIGNALLING (2020)
Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system
Mingming Jin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis
Qinhong Xu et al.
CELL BIOLOGY INTERNATIONAL (2020)
Chenopodium Quinoa and Salvia Hispanica Provide Immunonutritional Agonists to Ameliorate Hepatocarcinoma Severity under a High-Fat Diet
Jose Moises Laparra Llopis et al.
NUTRIENTS (2020)
Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma
Xia Qin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications
Youbo Zhao et al.
CELL REPORTS (2020)
Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis
Yoshiharu Muto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
Toshifumi Hoki et al.
JOURNAL OF SURGICAL RESEARCH (2019)
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
Vicenta Trujillo-Alonso et al.
NATURE NANOTECHNOLOGY (2019)
GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis
Giovanni C. Forcina et al.
PROTEOMICS (2019)
Iron Metabolism in Liver Cancer Stem Cells
Stefania Recalcati et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Cell death: a review of the major forms of apoptosis, necrosis and autophagy
Mark S. D'Arcy
CELL BIOLOGY INTERNATIONAL (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
Fan Yang et al.
EMBO JOURNAL (2019)
Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis
Nermi L. Parrow et al.
BLOOD (2019)
Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells
Tao Bai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Chen Liang et al.
ADVANCED MATERIALS (2019)
Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma
Wu Jing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway
Jingjing Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The chemical basis of ferroptosis
Marcus Conrad et al.
NATURE CHEMICAL BIOLOGY (2019)
Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway
Zhaoyan Kong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load
Carine Fillebeen et al.
BLOOD (2019)
Low Serum Hepcidin Is Associated With Reduced Short-Term Survival in Adults With Acute Liver Failure
Igor Spivak et al.
HEPATOLOGY (2019)
Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload
Andrew J. Schwartz et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells
Hongxia Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma
Xiao-Fei Zhang et al.
CELL DEATH DISCOVERY (2019)
Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
Irina Ingold et al.
CELL (2018)
Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
Yanyan Wei et al.
FRONTIERS IN PHYSIOLOGY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Rongshou Zheng et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Iron and Ferroptosis: A Still Ill-Defined Liaison
Sebastian Doll et al.
IUBMB LIFE (2017)
Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
Yeonhwa Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Thomas Efferth
SEMINARS IN CANCER BIOLOGY (2017)
Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib
Hongping Xia et al.
CELL DEATH DISCOVERY (2017)
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells
Tao Bai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Iron depletion enhances the effect of sorafenib in hepatocarcinoma
Shinichi Urano et al.
CANCER BIOLOGY & THERAPY (2016)
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Atsushi Umemura et al.
CANCER CELL (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis
Xiaofang Sun et al.
HEPATOLOGY (2016)
Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma
Chun Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
Aline Houessinon et al.
MOLECULAR CANCER (2016)
Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity
Charlene Brault et al.
GUT (2016)
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
Christophe Louandre et al.
CANCER LETTERS (2015)
GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues
E. Guerriero et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2015)
Nrf2, but not -catenin, mutation represents an early event in rat hepatocarcinogenesis
Patrizia Zavattari et al.
HEPATOLOGY (2015)
Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression
Pei-Pei Hao et al.
JOURNAL OF HEPATOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
HSPB1 as a novel regulator of ferroptotic cancer cell death
X. Sun et al.
ONCOGENE (2015)
Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4
Ming Cui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
MicroRNA/Gene Profiling Unveils Early Molecular Changes and Nuclear Factor Erythroid Related Factor 2 (NRF2) Activation in a Rat Model Recapitulating Human Hepatocellular Carcinoma (HCC)
Annalisa Petrelli et al.
HEPATOLOGY (2014)
SELENOPROTEINS: MOLECULAR PATHWAYS AND PHYSIOLOGICAL ROLES
Vyacheslav M. Labunskyy et al.
PHYSIOLOGICAL REVIEWS (2014)
Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function
Jia Shen et al.
CELL REPORTS (2014)
p38α Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen Species
Toshiharu Sakurai et al.
CANCER RESEARCH (2013)
A novel synergistic effect of iron depletion on antiangiogenic cancer therapy
Toshiaki Ohara et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Christophe Louandre et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Nogo/RTN4 isoforms and RTN3 expression protect SH-SY5Y cells against multiple death insults
Felicia Yu Hsuan Teng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
Yoshinobu Ichimura et al.
MOLECULAR CELL (2013)
A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and Function
Tal Ilani et al.
SCIENCE (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial-Mesenchymal Transition-like Phenomenon
Ho Min Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
Norie Sawada et al.
GASTROENTEROLOGY (2012)
Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma
Nataliya Rohr-Udilova et al.
HEPATOLOGY (2012)
Translocation of HSP27 into liver cancer cell nucleus may be associated with phosphorylation and O-GlcNAc glycosylation
Kun Guo et al.
ONCOLOGY REPORTS (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α
Karsten H. Weylandt et al.
CARCINOGENESIS (2011)
The FBXL5-IRP2 Axis Is Integral to Control of Iron Metabolism In Vivo
Toshiro Moroishi et al.
CELL METABOLISM (2011)
Early development of sigma-receptor ligands
Sanju Narayanan et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis
Paola Dongiovanni et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
miR-17-5p Promotes Migration of Human Hepatocellular Carcinoma Cells Through the P38 Mitogen-Activated Protein Kinase-Heat Shock Protein 27 Pathway
Fu Yang et al.
HEPATOLOGY (2010)
Detergent-Resistant Microdomains Determine the Localization of σ-1 Receptors to the Endoplasmic Reticulum-Mitochondria Junction
Teruo Hayashi et al.
MOLECULAR PHARMACOLOGY (2010)
Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis
Kun Guo et al.
BMC CANCER (2009)
Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells
Aanchal Sharma et al.
CANCER BIOLOGY & THERAPY (2009)
Iron in NASH, chronic liver diseases and HCC: How much iron is too much?
Antonello Pietrangelo
JOURNAL OF HEPATOLOGY (2009)
Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2
Kyu Lim et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
Phosphorylated heat shock protein 27 represses growth of hepatocellular carcinoma via inhibition of extracellular signal-regulated kinase
Rie Matsushima-Nishiwaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site
Rudiger Schweigreiter et al.
PROTEOMICS (2007)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines
Christoph Schmoecker et al.
HEPATOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Metallothioneins in human tumors and potential roles in carcinogenesis
M. George Cherian et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Share Paper
